SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 195 filers reported holding SANGAMO THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.58 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $36 | -25.0% | 20,900 | +35.7% | 0.00% | – |
| Q4 2022 | $48 | -99.9% | 15,400 | -17.2% | 0.00% | – |
| Q3 2022 | $91,000 | -4.2% | 18,600 | -19.1% | 0.00% | – |
| Q2 2022 | $95,000 | -28.0% | 23,000 | +3.1% | 0.00% | – |
| Q1 2022 | $132,000 | -59.3% | 22,300 | -46.1% | 0.00% | – |
| Q4 2021 | $324,000 | -23.6% | 41,400 | -10.8% | 0.00% | – |
| Q3 2021 | $424,000 | -40.7% | 46,400 | -23.9% | 0.00% | -100.0% |
| Q2 2021 | $715,000 | -24.8% | 61,000 | -25.1% | 0.00% | 0.0% |
| Q1 2021 | $951,000 | -72.8% | 81,429 | -60.7% | 0.00% | -83.3% |
| Q4 2020 | $3,495,000 | +224.5% | 207,286 | +90.2% | 0.01% | +200.0% |
| Q3 2020 | $1,077,000 | -16.8% | 108,985 | -26.2% | 0.00% | -33.3% |
| Q2 2020 | $1,295,000 | +15.8% | 147,638 | -14.3% | 0.00% | 0.0% |
| Q1 2020 | $1,118,000 | -46.0% | 172,240 | -32.2% | 0.00% | -50.0% |
| Q4 2019 | $2,071,000 | -3.3% | 254,118 | +9.1% | 0.01% | 0.0% |
| Q3 2019 | $2,141,000 | -33.4% | 233,008 | -21.9% | 0.01% | -40.0% |
| Q2 2019 | $3,214,000 | -13.2% | 298,469 | -23.1% | 0.01% | 0.0% |
| Q1 2019 | $3,702,000 | -39.1% | 387,998 | -30.7% | 0.01% | -44.4% |
| Q4 2018 | $6,079,000 | -6.1% | 559,718 | +46.6% | 0.02% | +28.6% |
| Q3 2018 | $6,471,000 | +31.5% | 381,791 | +47.4% | 0.01% | +16.7% |
| Q2 2018 | $4,921,000 | 0.0% | 259,000 | 0.0% | 0.01% | 0.0% |
| Q1 2018 | $4,921,000 | -16.6% | 259,000 | -28.0% | 0.01% | -42.9% |
| Q4 2017 | $5,898,000 | +30.9% | 359,615 | +19.8% | 0.02% | +23.5% |
| Q3 2017 | $4,506,000 | +163.5% | 300,301 | +56.3% | 0.02% | +112.5% |
| Q2 2017 | $1,710,000 | +236.0% | 192,186 | +77.5% | 0.01% | +300.0% |
| Q1 2017 | $509,000 | +79.2% | 108,256 | +16.4% | 0.00% | 0.0% |
| Q4 2016 | $284,000 | -24.3% | 92,978 | +13.2% | 0.00% | 0.0% |
| Q3 2016 | $375,000 | -62.6% | 82,100 | -52.8% | 0.00% | -66.7% |
| Q2 2016 | $1,002,000 | – | 173,816 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lombard Odier Asset Management (Switzerland) SA | 1,539,994 | $11,550,000 | 0.74% |
| Golden State Equity Partners | 143,768 | $1,078,000 | 0.54% |
| Rhenman & Partners Asset Management AB | 765,000 | $5,975,000 | 0.40% |
| WASATCH ADVISORS LP | 10,960,982 | $82,207,000 | 0.34% |
| KLK CAPITAL MANAGEMENT LLC | 44,323 | $332,000 | 0.32% |
| EMC Capital Management | 61,394 | $460,000 | 0.25% |
| Rokos Capital Management LLP | 539,860 | $4,108,000 | 0.25% |
| Long Focus Capital Management, LLC | 245,000 | $1,838,000 | 0.24% |
| Vanguard Capital Wealth Advisors | 33,380 | $250,000 | 0.18% |
| Fort Sheridan Advisors LLC | 74,898 | $562,000 | 0.16% |